BA
NEOS

Bridge Advisory’s Neos Therapeutics, Inc NEOS Stock Holding History

Bridge Advisory’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,564
Closed -$15K – 95
2020
Q4 		$15K Buy
+23,564
New +$14.6K 0.01% 79

Bridge Advisory's NEOS Position: Q1 2021 in Review

Bridge Advisory sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 23,564 shares — an estimated $15K sold.

Bridge Advisory first reported a position in NEOS in Q4 2020 and held it in 1 quarter. The position peaked at $15K in Q4 2020. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

  • Bridge Advisory reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
  • Bridge Advisory sold 23,564 Neos Therapeutics, Inc shares in Q1 2021, an estimated $15K.
  • Bridge Advisory first reported a position in Neos Therapeutics, Inc in Q4 2020 and held it in 1 quarter.
  • Bridge Advisory's Neos Therapeutics, Inc position peaked at $15K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Bridge Advisory's 13F filing for Q1 2021, filed 6 May 2021.